1. Home
  2. CDNA vs SMBK Comparison

CDNA vs SMBK Comparison

Compare CDNA & SMBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CDNA
  • SMBK
  • Stock Information
  • Founded
  • CDNA 1998
  • SMBK N/A
  • Country
  • CDNA United States
  • SMBK United States
  • Employees
  • CDNA N/A
  • SMBK N/A
  • Industry
  • CDNA Medical Specialities
  • SMBK Major Banks
  • Sector
  • CDNA Health Care
  • SMBK Finance
  • Exchange
  • CDNA Nasdaq
  • SMBK Nasdaq
  • Market Cap
  • CDNA 712.2M
  • SMBK 608.1M
  • IPO Year
  • CDNA 2014
  • SMBK N/A
  • Fundamental
  • Price
  • CDNA $14.49
  • SMBK $35.38
  • Analyst Decision
  • CDNA Buy
  • SMBK Buy
  • Analyst Count
  • CDNA 8
  • SMBK 4
  • Target Price
  • CDNA $26.86
  • SMBK $38.13
  • AVG Volume (30 Days)
  • CDNA 951.2K
  • SMBK 65.1K
  • Earning Date
  • CDNA 11-04-2025
  • SMBK 10-21-2025
  • Dividend Yield
  • CDNA N/A
  • SMBK 0.91%
  • EPS Growth
  • CDNA N/A
  • SMBK 41.99
  • EPS
  • CDNA 1.00
  • SMBK 2.74
  • Revenue
  • CDNA $340,826,000.00
  • SMBK $188,204,000.00
  • Revenue This Year
  • CDNA $12.73
  • SMBK $22.13
  • Revenue Next Year
  • CDNA $11.90
  • SMBK $10.21
  • P/E Ratio
  • CDNA $14.81
  • SMBK $12.88
  • Revenue Growth
  • CDNA 14.72
  • SMBK 18.22
  • 52 Week Low
  • CDNA $10.96
  • SMBK $26.31
  • 52 Week High
  • CDNA $26.37
  • SMBK $37.92
  • Technical
  • Relative Strength Index (RSI)
  • CDNA 48.56
  • SMBK 51.18
  • Support Level
  • CDNA $14.23
  • SMBK $34.28
  • Resistance Level
  • CDNA $15.29
  • SMBK $35.82
  • Average True Range (ATR)
  • CDNA 0.63
  • SMBK 1.12
  • MACD
  • CDNA -0.05
  • SMBK 0.06
  • Stochastic Oscillator
  • CDNA 30.42
  • SMBK 68.48

About CDNA CareDx Inc.

CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.

About SMBK SmartFinancial Inc.

SmartFinancial Inc operates as a bank holding company for SmartBank. It offers various banking and financial services to individuals and corporate customers. The principal business of the Bank consists of attracting deposits from the general public and investing those funds, together with funds generated from operations and from principal and interest payments on loans, mainly in commercial loans, commercial and residential real estate loans, consumer loans, and residential and commercial construction loans. The primary source of revenue is interest income from earning assets, namely loans and securities.

Share on Social Networks: